Scientists Link Defective Gene with Immunity Diseases


Scientists Link Defective Gene with Immunity Diseases

A recent study has found that defective genes in humans can trigger diseases like rheumatoid arthritis, diabetes, lupus and other autoimmune. The study was conducted by scientists at Mount Sinai Hospital.

For a period of five years, the researchers have tried to figure out as to how the mutant gene PTPN22 increases the risk for rheumatoid arthritis, type 1 diabetes, lupus, Graves disease and other autoimmune disorders.

Dr. Katherine Siminovitch, a Senior Investigator at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital and a University of Toronto Professor said, “Our findings are particularly exciting because the study sets a new precedent for studying arthritis and other autoimmune disorders”.

The researchers informed that changes in gene, which produces a protein that suppresses immune cell responses, could make the immunity system attack its own cells. It has been reported that severe changes in the gene makes the proteins to disappear making the immunity system to attack its own helpful cells.

It is believed that the findings of the study would pave way to understand the propensity of the severity in patients with autoimmune disorders. Moreover, the study would also prove helpful in findings new drugs to treat the disease.

Latest News

Deutsche Bank Q3 Loss may be a Record One in a Decade
Volkswagen Scandal Worries the City of Wolfsburg
Strong Component Sale and Weak Won help Samsung’s Third Quarter Profits
Is the U.S. Shale Oil Boom Heading Towards the Beginning of Its End?
Volkswagen Plans to Launch a Recall in January and Fix the Affected Diesel Cars
BOJ Keep Record Stimulus Unchanged
BP Plc will Pay $20 Billion as Penalties for the Deadly Oil Spill of 2010
Ben Bernanke says Larger Number of Executives Involved in 2008 Financial Crisis
United’s New CEO Oscar Muñoz Aims at Improving relation with Workers
The September Job Number Hint at a Sluggish Patch
First Data Launches its IPO, Targets to Raise Up to $3.7 Billion
ConAgra’s Head Quarter Move Announcement gets Positive but ‘Muted’